Home

Eric W Roberts

CIK 1576244 · CHIEF BUSINESS OFFICER · last filed 2026-08-21

Eric W Roberts is a CHIEF BUSINESS OFFICER who has filed 105 SEC Form 4 insider transactions across 6 companies since 2015. The most recent filing, for CALC, was dated Aug 21, 2026. Across all open-market trades the lifetime net is +$122.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $270.3K across reported positions. 4 SEC filings were submitted jointly with Valence CDK SPV, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$270.3K

Companies

6

Total Filings

105

Lifetime Open-Market Net

$122.7K

Filer Profile

Reported Address
VALENCE LIFE SCIENCES LLC
500 PARK AVENUE 9TH FLOOR
NEW YORK, NY 10022
Related Filers
Valence CDK SPV, L.P. — 4 joint filings, latest 2016-07-12
Valence Life Sciences GP II LLC — 4 joint filings, latest 2016-07-12
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CALC CHIEF BUSINESS OFFICER 136,509 $1.98 $270.3K $407.3K 40 2026-08-21
CalciMedica, Inc. (SCPH) Delisted CHIEF BUSINESS OFFICER 167,706 $5.67 $950.9K $246.1K 5 2024-11-06
CalciMedica, Inc. (GRAY) Delisted Chief Business Officer 66,228 $5.50 $364.3K $0 1 2023-03-22
VIVUS INC (VVUS) Delisted Director 16,660 — — $41.0K 36 2019-03-04
Invuity, Inc. (IVTY) Delisted Director 34,246 — — -$571.7K 22 2018-10-23
Celator Pharmaceuticals Inc (CPXX) Delisted 0 — — $0 1 2016-07-12

Recent Filings

105 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-21 CALC Grant (A) — $0 EDGAR
2026-06-29 CALC Grant (A) +186,729 $150.0K EDGAR
2026-04-07 CALC Grant (A) — $0 EDGAR
2025-09-22 CALC Buy (P) +2,500 $7.7K EDGAR
2025-09-17 CALC Buy (P) +3,400 $9.1K EDGAR
2025-09-15 CALC Buy (P) +5,000 $15.6K EDGAR
2025-09-11 CALC Buy (P) +2,343 $7.4K EDGAR
2025-09-02 CALC Buy (P) +10,000 $28.5K EDGAR
2025-08-25 CALC Buy (P) +3,508 $9.8K EDGAR
2025-08-21 CALC Mixed +18,000 $31.2K EDGAR
Showing 1–10 of 105
Page 1 of 11
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.